ArticleCancers2019

RCBTB1 Deletion Is Associated with Metastatic Outcome and Contributes to Docetaxel Resistance in Nontranslocation-Related Pleomorphic Sarcomas.

Olivier Mauduit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.